PacBio to Present at Upcoming Investor Conferences

MENLO PARK, Calif., Nov. 11, 2022 /PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that it will be participating in the following upcoming investor conferences: Canaccord Genuity MedTech, Diagnostics and...

Click to view original post